Siavash B. Kalkhoran

67 Chenies Mews
London, ENG WC1E6HX, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Inter-organ communication: pathways and targets to cardioprotection and neuro-protection. A report from the 12th Hatter Cardiovascular Institute workshop.

Inter-organ communication: pathways and targets to cardioprotection and neuro-protection. A report from the 12th Hatter Cardiovascular Institute workshop.

Journal: Basic research in cardiology

Published: December 04, 2024

Effect of Remote Ischaemic Conditioning on the Inflammatory Cytokine Cascade of COVID-19 (RIC in COVID-19): a Randomized Controlled Trial.

Effect of Remote Ischaemic Conditioning on the Inflammatory Cytokine Cascade of COVID-19 (RIC in COVID-19): a Randomized Controlled Trial.

Journal: Cardiovascular drugs and therapy

Published: November 20, 2022

Correction to: RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.

Correction to: RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.

Journal: Cardiovascular drugs and therapy

Published: July 07, 2021

Correction: Hearts deficient in both Mfn1 and Mfn2 are protected against acute myocardial infarction.

Correction: Hearts deficient in both Mfn1 and Mfn2 are protected against acute myocardial infarction.

Journal: Cell death & disease

Published: July 01, 2021

RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.

RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.

Journal: Cardiovascular drugs and therapy

Published: June 16, 2021

Mitochondrial shaping proteins as novel treatment targets for cardiomyopathies.

Mitochondrial shaping proteins as novel treatment targets for cardiomyopathies.

Journal: Conditioning medicine

Published: November 02, 2020

Hydralazine protects the heart against acute ischaemia/reperfusion injury by inhibiting Drp1-mediated mitochondrial fission.

Hydralazine protects the heart against acute ischaemia/reperfusion injury by inhibiting Drp1-mediated mitochondrial fission.

Journal: Cardiovascular research

Published: February 21, 2020

Unique morphological characteristics of mitochondrial subtypes in the heart: the effect of ischemia and ischemic preconditioning.

Unique morphological characteristics of mitochondrial subtypes in the heart: the effect of ischemia and ischemic preconditioning.

Journal: Discoveries (Craiova, Romania)

Published: July 25, 2017

An automated workflow for segmenting single adult cardiac cells from large-volume serial block-face scanning electron microscopy data.

An automated workflow for segmenting single adult cardiac cells from large-volume serial block-face scanning electron microscopy data.

Journal: Journal of structural biology

Published: May 26, 2017

Mitochondrial-Shaping Proteins in Cardiac Health and Disease - the Long and the Short of It!

Mitochondrial-Shaping Proteins in Cardiac Health and Disease - the Long and the Short of It!

Journal: Cardiovascular drugs and therapy

Published: February 13, 2017

From basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: meeting report from the third international symposium on "New frontiers in cardiovascular research".

From basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: meeting report from the third international symposium on "New frontiers in cardiovascular research".

Journal: Basic research in cardiology

Published: August 14, 2016

Hearts deficient in both Mfn1 and Mfn2 are protected against acute myocardial infarction.

Hearts deficient in both Mfn1 and Mfn2 are protected against acute myocardial infarction.

Journal: Cell death & disease

Published: December 14, 2015

Showing 1-12 of 15

Last Updated: 09/26/2026